Authors: Spinelli FR, Conti F, Gadina M
PMID: 32385052 DOI: 10.1126/sciimmunol.abc5367
JAK kinase inhibitors are being investigated as a way of managing cytokine storm in severe COVID-19 patients.
Keywords: SARS-CoV-2, JAK inhibitors, COVID-19
Source: https://pubmed.ncbi.nlm.nih.gov/32385052/
Archive: https://archive.ph/Jwcrd
FLCCC Alliance
2001 L St. NW Suite 500
Washington, DC 20036
FLCCC Alliance
2001 L St. NW Suite 500
Washington, DC 20036
©2020–2023 All Rights Reserved FLCCC Alliance. The information contained or presented on this website is for educational purposes only. Information on this site is NOT intended to serve as a substitute for diagnosis, treatment, or advice from a qualified, licensed medical professional. The facts presented are offered as information only in order to empower you – our protocol is not medical advice – and in no way should anyone infer that we, even though we are physicians, or anyone appearing in any content on this website are practicing medicine, it is for educational purposes only. Any treatment protocol you undertake should be discussed with your physician or other licensed medical professional. Seek the advice of a medical professional for proper application of ANY material on this site or our program to your specific situation. NEVER stop or change your medications without consulting your physician. If you are having an emergency contact your emergency services: in the USA that’s 911. FLCCC does not use SMS to conduct marketing campaigns, however, we are required to provide the following disclaimer: By providing my phone number to “FLCCC”, I agree and acknowledge that “FLCCC” may send text messages to my wireless phone number for any purpose. Message and data rates may apply. Message frequency will vary, and you will be able to Opt-out by replying “STOP”. For more information on how your data will be handled please see our privacy policy. Please read our complete disclaimers.
© Copyright 2023. FLCCC Alliance. All Rights Reserved.
